(Q35225200)

7 August 2017

1 reference

title

Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome (English)

1 reference

cytomegalovirus retinitis

7 August 2017

0 references

1 reference

M. H. Heinemann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310570

11 September 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

7 August 2017

14 February 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1310570

full work available at URL

11 September 2022

https://api.elsevier.com/content/article/PII:0002934392903315?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

https://api.elsevier.com/content/article/PII:0002934392903315?httpAccept=text/plain

1 December 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

American Journal of Medicine

1 December 2023

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

12S-16S

1 reference

Acquired immunodeficiency syndrome (AIDS).

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Treatment of cytomegalovirus retinitis with ganciclovir

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Atypical retinitis in patients with the acquired immunodeficiency syndrome

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Cytomegalovirus retinitis and acquired immunodeficiency syndrome

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Acquired Immune Deficiency Syndrome Retinopathy, Pneumocystis, and Cotton-Wool Spots

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Microvascular aspects of acquired immune deficiency syndrome retinopathy

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Resolution of cytomegalovirus retinitis with zidovudine therapy. Case report

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90331-5

1 December 2023

Identifiers

DOI

1 reference

7 August 2017

1 reference